Abstract
Background and Aims: Vascular Endothelial Growth Factor-A (VEGF-A -) is a biomarker of endothelial dysfunction (ED), which is involved in the development of vascular disorders and is the earliest marker of ED. Purpose was to study changes of VEGF-A level and lipids in patients with comorbid course of arterial hypertension (AH), type 2 diabetes mellitus (t2DM) and subclinical hypothyroidism (SH) for early diagnosis of vascular disorders and timely management.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
